AKT1 and polycystic ovary syndrome: Network pharmacology analysis identified key signalling pathways, including the PI3K-Akt, chemokine, cAMP, and MAPK signalling pathways, which are closely associated with chemerin and may contribute to the therapeutic effects of bile acids in the treatment of PCOS.